Long-term survivors of small cell carcinoma of the lung

Georgia Boyce Vogelsang, Martin D. Abeloff, David S Ettinger, Susan V. Booker

Research output: Contribution to journalArticle

Abstract

Small cell carcinoma of the lung has been shown to be exquisitely responsive to chemotherapy. Unfortunately, these responses are often short in duration and long-term disease-free survival is infrequent. This review of the records of all patients with small cell carcinoma of the lung treated on protocol at The Johns Hopkins Oncology Center from 1973 to 1982 showed that 25 of 225 (11.1 percent) survived two years or longer. Patients with limited disease (20 of 94) and patients with a complete response (15 of 72) had greater two-year survival than those with extensive disease (five of 131) or partial remission (eight of 104). However, 18 of the 25 long-term survivors eventually had relapses, and relapse occurred as late as eight years after diagnosis. This study further emphasizes the impressive discrepancy between the rate and magnitude of the initial response and ultimate survival in patients with small cell carcinoma of the lung.

Original languageEnglish (US)
Pages (from-to)49-56
Number of pages8
JournalAmerican Journal of Medicine
Volume79
Issue number1
DOIs
StatePublished - 1985

Fingerprint

Small Cell Lung Carcinoma
Survivors
Recurrence
Survival
Disease-Free Survival
Drug Therapy

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Long-term survivors of small cell carcinoma of the lung. / Vogelsang, Georgia Boyce; Abeloff, Martin D.; Ettinger, David S; Booker, Susan V.

In: American Journal of Medicine, Vol. 79, No. 1, 1985, p. 49-56.

Research output: Contribution to journalArticle

@article{ff55ac0e56fe434a9691c43b6c114571,
title = "Long-term survivors of small cell carcinoma of the lung",
abstract = "Small cell carcinoma of the lung has been shown to be exquisitely responsive to chemotherapy. Unfortunately, these responses are often short in duration and long-term disease-free survival is infrequent. This review of the records of all patients with small cell carcinoma of the lung treated on protocol at The Johns Hopkins Oncology Center from 1973 to 1982 showed that 25 of 225 (11.1 percent) survived two years or longer. Patients with limited disease (20 of 94) and patients with a complete response (15 of 72) had greater two-year survival than those with extensive disease (five of 131) or partial remission (eight of 104). However, 18 of the 25 long-term survivors eventually had relapses, and relapse occurred as late as eight years after diagnosis. This study further emphasizes the impressive discrepancy between the rate and magnitude of the initial response and ultimate survival in patients with small cell carcinoma of the lung.",
author = "Vogelsang, {Georgia Boyce} and Abeloff, {Martin D.} and Ettinger, {David S} and Booker, {Susan V.}",
year = "1985",
doi = "10.1016/0002-9343(85)90545-5",
language = "English (US)",
volume = "79",
pages = "49--56",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Long-term survivors of small cell carcinoma of the lung

AU - Vogelsang, Georgia Boyce

AU - Abeloff, Martin D.

AU - Ettinger, David S

AU - Booker, Susan V.

PY - 1985

Y1 - 1985

N2 - Small cell carcinoma of the lung has been shown to be exquisitely responsive to chemotherapy. Unfortunately, these responses are often short in duration and long-term disease-free survival is infrequent. This review of the records of all patients with small cell carcinoma of the lung treated on protocol at The Johns Hopkins Oncology Center from 1973 to 1982 showed that 25 of 225 (11.1 percent) survived two years or longer. Patients with limited disease (20 of 94) and patients with a complete response (15 of 72) had greater two-year survival than those with extensive disease (five of 131) or partial remission (eight of 104). However, 18 of the 25 long-term survivors eventually had relapses, and relapse occurred as late as eight years after diagnosis. This study further emphasizes the impressive discrepancy between the rate and magnitude of the initial response and ultimate survival in patients with small cell carcinoma of the lung.

AB - Small cell carcinoma of the lung has been shown to be exquisitely responsive to chemotherapy. Unfortunately, these responses are often short in duration and long-term disease-free survival is infrequent. This review of the records of all patients with small cell carcinoma of the lung treated on protocol at The Johns Hopkins Oncology Center from 1973 to 1982 showed that 25 of 225 (11.1 percent) survived two years or longer. Patients with limited disease (20 of 94) and patients with a complete response (15 of 72) had greater two-year survival than those with extensive disease (five of 131) or partial remission (eight of 104). However, 18 of the 25 long-term survivors eventually had relapses, and relapse occurred as late as eight years after diagnosis. This study further emphasizes the impressive discrepancy between the rate and magnitude of the initial response and ultimate survival in patients with small cell carcinoma of the lung.

UR - http://www.scopus.com/inward/record.url?scp=0021845484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021845484&partnerID=8YFLogxK

U2 - 10.1016/0002-9343(85)90545-5

DO - 10.1016/0002-9343(85)90545-5

M3 - Article

C2 - 2990209

AN - SCOPUS:0021845484

VL - 79

SP - 49

EP - 56

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 1

ER -